Back

Fragmented sleep during pregnancy induces inflammation and tryptophan-kynurenine pathway metabolism: Importance of elevated fetal brain kynurenic acid

Wright, C. J.; Cox, J. H.; Milosavljevic, S.; Valafar, H.; Frizzell, N.; Pocivavsek, A.

2026-06-29 neuroscience
10.64898/2026.06.24.734303 bioRxiv
Show abstract

Maternal sleep disturbance is an underrecognized risk factor for adverse offspring outcomes. Prolonged sleep disruption can elicit inflammation, an established risk factor for neuropsychiatric disorders in offspring. Sleep disruptions and inflammation elevate tryptophan degradation via the kynurenine pathway (KP), increasing kynurenic acid (KYNA), a metabolite that inhibits glutamatergic and cholinergic neurotransmission and may thereby affect neurodevelopment. Because KYNA is elevated in the brains of individuals with neurodevelopmental psychotic illnesses, we hypothesize that prenatal KYNA elevation may represent a mechanism link between disturbed maternal sleep, inflammation, and adverse offspring neurodevelopmental health. To test this hypothesis, we employed a novel maternal sleep fragmentation (SleepFrag) paradigm during the final week of gestation. We found that six days of SleepFrag increased maternal plasma inflammatory markers, placental KP metabolism, sex-specific placental inflammation, and fetal brain KP metabolism, including elevated KYNA, without altering KP metabolism in maternal plasma or brain. A parallel embryonic kynurenine (EKyn) model was tested to increase prenatal KP metabolism via a maternal kynurenine-supplemented diet. EKyn increased maternal plasma kynurenine and KYNA, and fetal brain KYNA, with a male-specific increase in fetal brain KYNAto-kynurenine ratio, despite minimal effects on maternal sleep-wake architecture or inflammation. Together, these findings identify elevated fetal brain KYNA as a convergent outcome through which maternal sleep disruption, inflammation, and KP activation may influence sex-specific neurodevelopment. They further support the EKyn model as a translational tool for isolating consequences of increased prenatal KP metabolism. Protecting maternal sleep and stabilizing fetal brain KYNA levels may promote long-term offspring brain health.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
153 papers in training set
Top 0.2%
11.9%
2
Brain, Behavior, and Immunity
116 papers in training set
Top 0.1%
11.9%
3
Molecular Psychiatry
282 papers in training set
Top 0.5%
9.8%
4
Sleep
58 papers in training set
Top 0.2%
6.8%
5
Translational Psychiatry
260 papers in training set
Top 1%
5.5%
6
Biological Psychiatry Global Open Science
60 papers in training set
Top 0.1%
5.5%
50% of probability mass above
7
Biological Psychiatry
137 papers in training set
Top 0.9%
3.3%
8
Scientific Reports
3612 papers in training set
Top 33%
3.2%
9
The Journal of Neuroscience
1025 papers in training set
Top 5%
3.2%
10
eLife
5828 papers in training set
Top 41%
2.4%
11
Journal of Psychopharmacology
17 papers in training set
Top 0.2%
1.7%
12
Frontiers in Neuroscience
256 papers in training set
Top 4%
1.5%
13
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 30%
1.5%
14
PLOS ONE
5266 papers in training set
Top 55%
1.1%
15
Journal of Sleep Research
36 papers in training set
Top 0.4%
1.1%
16
Nature Communications
5641 papers in training set
Top 51%
1.1%
17
Sleep Advances
11 papers in training set
Top 0.2%
1.1%
18
iScience
1154 papers in training set
Top 29%
1.0%
19
Sleep Medicine
19 papers in training set
Top 0.3%
1.0%
20
Genes, Brain and Behavior
30 papers in training set
Top 0.5%
0.8%
21
Neuroscience
97 papers in training set
Top 2%
0.8%
22
ACS Chemical Neuroscience
67 papers in training set
Top 2%
0.8%
23
eneuro
439 papers in training set
Top 8%
0.8%
24
Communications Biology
993 papers in training set
Top 34%
0.6%
25
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 1%
0.6%